Digital ischemia triggered by coronavirus disease 2019 in a patient under cemiplimab treatment.
作者信息
Serra-García Laura, Bosch-Amate Xavier, Alamon-Reig Francesc, Giavedoni Priscila, Fuertes Irene, Morgado-Carrasco Daniel, Iglesias Pablo, Puig Susana, Mascaró José M
机构信息
Department of Dermatology, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
出版信息
Int J Dermatol. 2021 Jan;60(1):e30-e32. doi: 10.1111/ijd.15239. Epub 2020 Oct 11.
Abstract
摘要
相似文献
1
Digital ischemia triggered by coronavirus disease 2019 in a patient under cemiplimab treatment.一名接受西米普利单抗治疗的患者出现由2019冠状病毒病引发的手指缺血。
Int J Dermatol. 2021 Jan;60(1):e30-e32. doi: 10.1111/ijd.15239. Epub 2020 Oct 11.
2
CorrespondenceMetastatic basal cell carcinoma with neuroendocrine differentiation: complete response to cemiplimab.通信转移性基底细胞癌伴神经内分泌分化：对西米普利单抗完全缓解
Clin Exp Dermatol. 2024 Aug 22;49(9):1060-1062. doi: 10.1093/ced/llae099.
3
Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.帕博利珠单抗治疗转移性黑色素瘤期间浅表基底细胞癌持续存在。
Eur J Dermatol. 2021 Feb 1;31(1):99-100. doi: 10.1684/ejd.2020.3958.
4
Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.肾移植后晚期皮肤鳞状细胞癌患者成功使用西米普利单抗治疗
JCO Oncol Pract. 2020 Mar;16(3):137-138. doi: 10.1200/JOP.19.00567. Epub 2019 Nov 26.
5
RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma.瑞弗西单抗：首个获批用于治疗转移性或不可切除性皮肤鳞状细胞癌的药物。
Actas Dermosifiliogr (Engl Ed). 2020 Mar;111(2):161-163. doi: 10.1016/j.ad.2018.10.025. Epub 2019 Dec 24.
6
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.帕博利珠单抗治疗晚期基底细胞癌：一项研究者发起的概念验证研究。
J Am Acad Dermatol. 2019 Feb;80(2):564-566. doi: 10.1016/j.jaad.2018.08.017. Epub 2018 Aug 24.
7
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.局部晚期基底细胞癌患者停用西米普利单抗后的持久反应。
Clin Exp Dermatol. 2021 Dec;46(8):1612-1614. doi: 10.1111/ced.14804. Epub 2021 Jul 29.
8
Health-related quality of life in patients with metastatic basal cell carcinoma treated with cemiplimab: Analysis of a phase 2 trial.转移性基底细胞癌患者接受西普单抗治疗的健康相关生活质量：一项 2 期试验分析。
Cancer Med. 2024 Jul;13(14):e7360. doi: 10.1002/cam4.7360.
9
Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma.西米普利单抗治疗局部晚期皮肤鳞状细胞癌期间的放射回忆反应
Dermatol Ther. 2020 Nov;33(6):e14417. doi: 10.1111/dth.14417. Epub 2020 Oct 23.
10
Novel treatment of locally advanced cutaneous squamous cell carcinoma with cemiplimab: a case report.西米普利单抗治疗局部晚期皮肤鳞状细胞癌的新疗法：病例报告
Int J Dermatol. 2021 Feb;60(2):233-235. doi: 10.1111/ijd.15176. Epub 2020 Sep 21.
引用本文的文献
1
Unveiling the Enigma: Idiopathic Digital Infarction-A Case Report and Literature Review.揭开谜团：特发性指端梗死——病例报告与文献综述
Clin Case Rep. 2025 Jan 30;13(2):e70107. doi: 10.1002/ccr3.70107. eCollection 2025 Feb.
2
COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review.接受免疫检查点抑制剂治疗的癌症患者的COVID-19结局：一项系统综述。
J Immunother Precis Oncol. 2023 Feb 22;6(2):103-110. doi: 10.36401/JIPO-22-24. eCollection 2023 May.
本文引用的文献
1
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.COVID-19 大流行期间的自身炎症性和自身免疫性疾病。
J Autoimmun. 2020 Nov;114:102506. doi: 10.1016/j.jaut.2020.102506. Epub 2020 Jun 16.
2
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类：西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
3
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成：五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
4
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
5
Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review.与免疫检查点抑制剂相关的肢端血管坏死：病例报告并文献复习。
BMC Cancer. 2019 May 14;19(1):449. doi: 10.1186/s12885-019-5661-x.
Zotero 插件